Mark Bosco Saldanha
Fortune : 514 M $ au 31/05/2026
Fortune : 514 M $ au 31/05/2026
Mark Bosco Saldanha is the founder of Marksans Pharma Ltd., established in 1992, holding the titles of Chairman, CEO & Managing Director.
Current jobs include Chief Executive Officer at Time-Cap Laboratories, Inc.; Director at Nova Pharmaceuticals Australasia Pty Ltd.; Director at Marksans Pharma U.
K.
Ltd. since 2005; Director at Relonchem Ltd.; Director at Custom Coating, Inc.; Director at Marksans Pharma, Inc.; Director at Marksans Holdings Ltd.; Director at Marksans Realty LLC; and Director at Bell, Sons & Co. (Druggists) Ltd. since 2008.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 198 491 553 ( 43,8% ) | 514 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MARKSANS PHARMA LIMITED | Directeur Général | 06/10/2005 |
Marksans Pharma U. K. Ltd.
Marksans Pharma U. K. Ltd. Drugstore ChainsRetail Trade Supplies pharmaceutical products in the UK | Directeur/Membre du Conseil | 31/05/2005 |
Marksans Holdings Ltd. | Directeur/Membre du Conseil | - |
Bell, Sons & Co. (Druggists) Ltd.
Bell, Sons & Co. (Druggists) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures non-sterile, liquids, ointments and powder products | Directeur/Membre du Conseil | 18/01/2008 |
Relonchem Ltd.
Relonchem Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generics | Directeur/Membre du Conseil | - |
Nova Pharmaceuticals Australasia Pty Ltd.
Nova Pharmaceuticals Australasia Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and marketing of generic pharmaceutical products | Directeur/Membre du Conseil | - |
Marksans Pharma, Inc.
Marksans Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical formulations and ingredients | Directeur/Membre du Conseil | - |
Time-Cap Laboratories, Inc.
Time-Cap Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Offers pharmaceutical tablets and capsules | Directeur Général | - |
Marksans Realty LLC | Directeur/Membre du Conseil | - |
| ░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Marksans Pharma Ltd.
Marksans Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical formulations and ingredients | Health Technology |
Nova Pharmaceuticals Australasia Pty Ltd.
Nova Pharmaceuticals Australasia Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and marketing of generic pharmaceutical products | Commercial Services |
Bell, Sons & Co. (Druggists) Ltd.
Bell, Sons & Co. (Druggists) Ltd. Pharmaceuticals: MajorHealth Technology Manufactures non-sterile, liquids, ointments and powder products | Health Technology |
Marksans Pharma U. K. Ltd.
Marksans Pharma U. K. Ltd. Drugstore ChainsRetail Trade Supplies pharmaceutical products in the UK | Retail Trade |
Relonchem Ltd.
Relonchem Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generics | Health Technology |
Time-Cap Laboratories, Inc.
Time-Cap Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Offers pharmaceutical tablets and capsules | Health Technology |
Custom Coating, Inc.
Custom Coating, Inc. Construction MaterialsNon-Energy Minerals Provides coating services | Non-Energy Minerals |
Marksans Pharma, Inc.
Marksans Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical formulations and ingredients | Health Technology |
Marksans Holdings Ltd. | |
Marksans Realty LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national